Daan R Löke1, Roxan F C P A Helderman1,2, Jan Sijbrands1, Hans M Rodermond1,2, Pieter J Tanis3, Nicolaas A P Franken1,2, Arlene L Oei1,2, H Petra Kok1, Johannes Crezee1. 1. Department of Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The Netherlands. 2. Department for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The Netherlands. 3. Department for Surgery, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The Netherlands.
Abstract
BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is used for treating peritoneal metastases of various origins. Present HIPEC protocols have rarely been validated for relevant parameters such as optimal agent, duration and perfusate temperature. In vitro experiments are not completely representative of clinical circumstances. Therefore, a good preclinical in vivo HIPEC model is needed in which temperature distributions can be well-controlled and are stable throughout treatments. METHODS: We designed a setup able to generate and maintain a homogeneous flow during a 90-min HIPEC procedure using our in-house developed treatment planning tools and computer aided design (CAD) techniques. Twelve rats were treated with heated phosphate-buffered saline (PBS) using two catheter setups (one vs. four- inflows) and extensive thermometry. Simulated and measured thermal distribution and core temperatures were evaluated for the different setups. RESULTS: Overall, the four-inflow resulted in more stable and more homogeneous thermal distributions than the one-inflow, with lower standard deviations (0.79 °C vs. 1.41 °C at the outflow, respectively) and less thermal losses. The average thermal loss was 0.4 °C lower for rats treated with the four-inflow setup. Rat core temperatures were kept stable using occasional tail cooling, and rarely exceeded 39 °C. CONCLUSION: Increasing the number of inflow catheters from one to four resulted in increased flow and temperature homogeneity and stability. Tail cooling is an adequate technique to prevent rats from overheating during 90-min treatments. This validated design can improve accuracy in future in vivo experiments investigating the impact of relevant parameters on the efficacy of different HIPEC protocols.
BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is used for treating peritoneal metastases of various origins. Present HIPEC protocols have rarely been validated for relevant parameters such as optimal agent, duration and perfusate temperature. In vitro experiments are not completely representative of clinical circumstances. Therefore, a good preclinical in vivo HIPEC model is needed in which temperature distributions can be well-controlled and are stable throughout treatments. METHODS: We designed a setup able to generate and maintain a homogeneous flow during a 90-min HIPEC procedure using our in-house developed treatment planning tools and computer aided design (CAD) techniques. Twelve rats were treated with heated phosphate-buffered saline (PBS) using two catheter setups (one vs. four- inflows) and extensive thermometry. Simulated and measured thermal distribution and core temperatures were evaluated for the different setups. RESULTS: Overall, the four-inflow resulted in more stable and more homogeneous thermal distributions than the one-inflow, with lower standard deviations (0.79 °C vs. 1.41 °C at the outflow, respectively) and less thermal losses. The average thermal loss was 0.4 °C lower for rats treated with the four-inflow setup. Rat core temperatures were kept stable using occasional tail cooling, and rarely exceeded 39 °C. CONCLUSION: Increasing the number of inflow catheters from one to four resulted in increased flow and temperature homogeneity and stability. Tail cooling is an adequate technique to prevent rats from overheating during 90-min treatments. This validated design can improve accuracy in future in vivo experiments investigating the impact of relevant parameters on the efficacy of different HIPEC protocols.
Authors: Yvonne L B Klaver; Thijs Hendriks; Roger M L M Lomme; Harm J T Rutten; Robert P Bleichrodt; Ignace H J T de Hingh Journal: Ann Surg Oncol Date: 2011-08-12 Impact factor: 5.344
Authors: Kuno Lehmann; Andreas Rickenbacher; Jae-Hwi Jang; Christian E Oberkofler; René Vonlanthen; Lotta von Boehmer; Bostjan Humar; Rolf Graf; Philippe Gertsch; Pierre-Alain Clavien Journal: Ann Surg Date: 2012-11 Impact factor: 12.969
Authors: Robert A Nagourney; Steven Evans; Peter H Tran; Adam J Nagourney; Paul H Sugarbaker Journal: Eur J Surg Oncol Date: 2020-09-19 Impact factor: 4.424
Authors: H Petra Kok; Marcus Beck; Daan R Löke; Roxan F C P A Helderman; Geertjan van Tienhoven; Pirus Ghadjar; Peter Wust; Hans Crezee Journal: Int J Hyperthermia Date: 2020 Impact factor: 3.914
Authors: Roxan F C P A Helderman; Daan R Löke; H Petra Kok; Arlene L Oei; Pieter J Tanis; Nicolaas A P Klaas Franken; Johannes Crezee Journal: Cancers (Basel) Date: 2019-01-11 Impact factor: 6.639
Authors: Lieselotte Lemoine; Elsy Thijssen; Robert Carleer; Jirka Cops; Veerle Lemmens; Peter Van Eyken; Paul Sugarbaker; Kurt Van der Speeten Journal: Oncotarget Date: 2019-02-15
Authors: I Ubink; A C F Bolhaqueiro; S G Elias; D A E Raats; A Constantinides; N A Peters; E C E Wassenaar; I H J T de Hingh; K P Rovers; W M U van Grevenstein; M M Laclé; G J P L Kops; I H M Borel Rinkes; O Kranenburg Journal: Br J Surg Date: 2019-06-14 Impact factor: 6.939